12 September 2016
EKF Diagnostics Holdings plc
("EKF" or the "Company")
Grant of Options
EKF Diagnostics Holdings plc (AIM: EKF) announces that, on 12 September 2016, the Company granted options ("Options") over a total of 6,600,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") pursuant to the Company's Unapproved Share Option Plan. Of these Options, 5,800,000 were granted to Persons Discharging Managerial Responsibilities ("PDMRs") on behalf of the Company, with 800,000 granted to one other employee.
All Options will vest on 12 September 2019 subject to achievement by the individual recipient of specific performance-related criteria and continuous employment, except that they will vest automatically upon the sale of the Company. The Options are exercisable at 15 pence per Ordinary Share, with an expiry date for exercise of 12 September 2026.
The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
|
1
|
Details of the person discharging managerial responsibilities / person closely associated |
|
|
a)
|
Names |
Steven Wray - Head of Sales EMEA Gilbert Mejia - Head of Sales Americas Martyn Lewis - Head of Marketing Peter Coyne - Head of Operations Ed Hitchler - General Manager, EKF USA Steffan Borlich - General Manager, EKF Germany Salim Hamir - Company Secretary and Head of Corporate Affairs Colin Anderson - Deputy Finance Director
|
|
2
|
Reason for the notification |
|
|
a)
|
Position/status
|
See 1(a) above for positions - all classified as PDMRs of EKF |
|
b)
|
Initial notification /Amendment
|
Initial Notification |
|
3
|
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
|
a)
|
Name
|
EKF Diagnostics Holdings plc |
|
b)
|
LEI |
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
|
a)
|
Description of the financial instrument, type of instrument
|
In each case, the grant of Options on 12 September 2016 over Ordinary Shares |
|
b) |
Identification code
|
GB0031509804 |
|
c)
|
Nature of the transaction
|
Grant of Options over Ordinary Shares pursuant to the Company's Unapproved Share Option plan
|
|
d)
|
Price(s) and volume(s) |
Price - n/a Volume(s) Steven Wray - 800,000 Options Gilbert Mejia - 800,000 Options Martyn Lewis - 800,000 Options Peter Coyne - 800,000 Options Ed Hitchler - 800,000 Options Steffan Borlich - 800,000 Options Salim Hamir -500,000 Options Colin Anderson - 500,000 Options
|
|
d)
|
Aggregated information - Aggregated volume - Price |
N/a
|
|
e)
|
Date of the transaction |
12 September 2016 |
|
f)
|
Place of the transaction |
Outside a trading venue |
Name of authorised official of issuer responsible for making notification.
Salim Hamir
Company Secretary to EKF Diagnostics Holdings plc
For further information:
|
EKF Diagnostics Holdings plc |
Tel: 029 2071 0570 |
|
|
Julian Baines, CEO |
|
|
|
Richard Evans, FD & COO |
|
|
|
|
|
|
|
Panmure Gordon (UK) Limited |
Tel: 020 7886 2500 |
|
|
Peter Steel |
|
|
|
Freddy Crossley |
|
|
|
|
|
|
|
Walbrook PR Limited |
Tel: 020 7933 8780 or ekf@walbrookpr.com |
|
|
Paul McManus |
Mob: 07980 541 893 |
|
|
Lianne Cawthorne |
Mob: 07584 391 303 |
|
|
|
|
|